公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
2014 | One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. | Kao, CH; Wang, JY; Chuang, KH; Chuang, CH; Cheng, TC; Hsieh, YC; Tseng, YL; Chen, BM; Roffler, SR; Cheng, TL | Biomaterials 35(37), 9930-9940 | | | |
2014 | PET Imaging of beta-Glucuronidase Activity by an Activity-Based 124I-Trapping Probe for the Personalized Glucuronide Prodrug Targeted Therapy. | Su, YC; Cheng, TC; Leu, YL; Roffler, SR; Wang, JY; Chuang, CH; Kao, CH; Chen, KC; Wang, HE; Cheng, TL | Molecular Cancer Therapeutics 13(12), 2852-2863 | | | |
2016 | Reloadable multidrug capturing delivery system for targeted ischemic disease treatment | Wu, JP; Cheng, B; Roffler, SR; Lundy, DJ; Yen, CY; Chen, P; Lai, JJ; Pun, SH; Stayton, PS; Hsieh, PC | Science Translational Medicine 8(365), 365ra160 | | | |
2015 | Selective Delivery of PEGylated Compounds to Tumor Cells by anti-PEG Hybrid Antibodies. | Tung, HY; Su, YC; Chen, BM; Burnouf, PA; Huang, WC; Chuang, KH; Yan, YT; Cheng, TL; Roffler, SR | Molecular cancer therapeutics Epub ahead of print | | | |
2010 | Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. | Su, YC; Chen, BM; Chuang, KH; Cheng, TL; Roffler, SR | Bioconjugate chemistry 21(7), 1264-1270 | | | |
2016 | Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation. | Prijovich, ZM; Burnouf, PA; Chou, HC; Huang, PT; Chen, KC; Cheng, TL; Leu, YL; Roffler, SR | Molecular pharmaceutics 13(4), 1242-50 | | | |
2005 | Topoisomerase I activity in ovarian cancer is a predictor of sensitivity to topotecan chemotherapy | Yu, MH; Roffler, SR; Chen, BM | Taiwan Gynecol Oncol 2, 14-22 | | | |
2015 | Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human beta-glucuronidase to compensate for alpha-iduronidase deficiency. | Chuang, HY; Suen, CS; Hwang, MJ; Roffler, SR | PROTEIN ENGINEERING DESIGN & SELECTION 28(11), 519-530 | | | |
2009 | Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. | Shieh, SJ; Chou, FC; Yu, PN; Lin, WC; Chang, DM; Roffler, SR; Sytwu, HK | Journal of immunology 183(4), 2277-2285 | | | |
2010 | Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist. | Chang, CM; Lo, CH; Shih, YM; Chen, Y; Wu, PY; Tsuneyama, K; Roffler, SR; Tao, MH | Human gene therapy 21(5), 611-621 | | | |
2009 | Tumor-localized ligation of CD3 and CD28 with systemic regulatory T cell depletion induces potent innate and adaptive antitumor responses | Lee, CH; Chiang, YH; Chang, SE; Chong, CL; Cheng, BM; Roffler, SR | Clinical Cancer Research 15,2756-2766 | | | |
2016 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. | Hsieh, YC; Cheng, TC; Wang, HE; Li, JJ; Lin, WW; Huang, CC; Chuang, CH; Wang, YT; Wang, JY; Roffler, SR; Chuang, KH; Cheng, TL | Scientific reports 6, 39119 | | | |